PMID- 24223975 OWN - NLM STAT- MEDLINE DCOM- 20140818 LR - 20211021 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 8 IP - 11 DP - 2013 TI - Concerted in vitro trimming of viral HLA-B27-restricted ligands by human ERAP1 and ERAP2 aminopeptidases. PG - e79596 LID - 10.1371/journal.pone.0079596 [doi] LID - e79596 AB - In the classical human leukocyte antigen (HLA) class I antigen processing and presentation pathway, the antigenic peptides are generated from viral proteins by multiple proteolytic cleavages of the proteasome (and in some cases other cytosolic proteases) and transported to the endoplasmic reticulum (ER) lumen where they are exposed to aminopeptidase activity. In human cells, two different ER-resident enzymes, ERAP1 and ERAP2, can trim the N-terminally extended residues of peptide precursors. In this study, the possible cooperative effect of generating five naturally processed HLA-B27 ligands by both proteases was analyzed. We identified differences in the products obtained with increased detection of natural HLA-B27 ligands by comparing double versus single enzyme digestions by mass spectrometry analysis. These in vitro data suggest that each enzyme can use the degradation products of the other as a substrate for new N-terminal trimming, indicating concerted aminoproteolytic activity of ERAP 1 and ERAP2. FAU - Lorente, Elena AU - Lorente E AD - Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Madrid, Spain. FAU - Barriga, Alejandro AU - Barriga A FAU - Johnstone, Carolina AU - Johnstone C FAU - Mir, Carmen AU - Mir C FAU - Jimenez, Mercedes AU - Jimenez M FAU - Lopez, Daniel AU - Lopez D LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20131101 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (HLA-B27 Antigen) RN - 0 (Ligands) RN - 0 (Minor Histocompatibility Antigens) RN - 0 (Viral Proteins) RN - EC 3.4.11.- (Aminopeptidases) RN - EC 3.4.11.- (ERAP1 protein, human) RN - EC 3.4.11.- (ERAP2 protein, human) SB - IM MH - Amino Acid Sequence MH - Aminopeptidases/chemistry/*metabolism MH - HLA-B27 Antigen/*metabolism MH - Humans MH - Ligands MH - Minor Histocompatibility Antigens MH - Molecular Sequence Data MH - Protein Multimerization MH - Protein Structure, Quaternary MH - *Proteolysis MH - Respiratory Syncytial Virus, Human/metabolism MH - Viral Proteins/chemistry/*metabolism PMC - PMC3815102 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2013/11/14 06:00 MHDA- 2014/08/19 06:00 PMCR- 2013/11/01 CRDT- 2013/11/14 06:00 PHST- 2013/04/11 00:00 [received] PHST- 2013/09/24 00:00 [accepted] PHST- 2013/11/14 06:00 [entrez] PHST- 2013/11/14 06:00 [pubmed] PHST- 2014/08/19 06:00 [medline] PHST- 2013/11/01 00:00 [pmc-release] AID - PONE-D-13-14999 [pii] AID - 10.1371/journal.pone.0079596 [doi] PST - epublish SO - PLoS One. 2013 Nov 1;8(11):e79596. doi: 10.1371/journal.pone.0079596. eCollection 2013.